Researchers did a cross-sectional analysis of U.S. national and local insurance companies for lumbar microdiscectomy coverage policies, according to the study published in the February 2024 issue of the IJSS. Preapproval criteria were consolidated into four main categories: symptom criteria, examination criteria, imaging criteria and conservative treatment.
The study assessed 13 insurers that equated to about 31% of the market share in the U.S. Descriptions of symptom criteria, imaging criteria, and the definition of conservative treatment had “substantial differences” compared to what NASS determined.
The study concluded, “Although a guideline to establish medical necessity was developed by NASS, many insurance companies have created their own guidelines, which have resulted in inconsistent management based on geographic location and selected provider.”
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
